Listed by the USPTO as ARMATO JR, DENNIS IGNATIUS
Tech Center 1600 • Art Units: 1651 1657 1682
This examiner grants 43% of resolved cases
ARMATO JR, DENNIS IGNATIUS examines in tech center 1600 and art unit 1651. The record contains 21 resolved cases, with an allowance rate of 42.9% and a median of 1250 days to allowance. Interview lift is 80.0%, indicating a strong positive association between interviews and allowance outcomes in the recorded cases.
The leading companies are Wisconsin Alumni Research Foundation, DSM IP Assets B.V., and Amgen Inc. The leading firms are COOLEY LLP, LEYDIG VOIT & MAYER, LTD, and Neal, Gerber & Eisenberg LLP. Because the record contains 21 resolved cases, the measures are directional. The allowance rate supports careful claim and evidence development, while the interview lift supports targeted examiner engagement. The 1250-day median makes early prosecution planning important.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18508825 | GENETICALLY ENCODED SYNTHETIC REACTION-DIFFUSION SYSTEM THAT CAN GENERATE PROGRAMMABLE OSCILLATIONS, PATTERNS, AND SPATIOTEMPORAL SIGNALING CIRCUITS IN MAMMALIAN CELLS | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18561123 | METHODS OF PRODUCTING HMO BLEND PROFILES WITH LNFP-1 AND 2'-FL AS THE PREDOMINANT COMPOUNDS | Final Rejection | DSM IP Assets B.V. |
| 18026678 | METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS | Non-Final OA | AMGEN INC. |
| 17159870 | FUNGAL SPECIES, COMPOSITIONS DERIVED THEREFROM, AND USES THEREOF | Final Rejection | President and Fellows of Harvard College |
| 17283007 | REPORTER CONSTRUCTS FOR NANOPORE-BASED DETECTION OF BIOLOGICAL ACTIVITY | Final Rejection | UNIVERSITY OF WASHINGTON |
| 18276331 | PROCESS | Non-Final OA | GIVAUDAN SA |
| 18746141 | NOMADIC BACTERIA AND USES THEREOF | Non-Final OA | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
| 17775101 | SYNTHETIC ALPHA-SECRETASE AND USE THEREOF | Final Rejection | INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY |
| 18699491 | MICROORGANISM HAVING ABILITY TO PRODUCE N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE AND METHOD FOR PRODUCING N-ACETYLNEURAMINIC ACID AND/OR N-ACETYLNEURAMINIC ACID-CONTAINING CARBOHYDRATE USING SAID MICROORGANISM | Non-Final OA | KYOWA HAKKO BIO CO., LTD. |
| 18275331 | BILE SALTS BACTOSENSOR AND USE THEREOF FOR DIAGNOSITC AND THERAPEUTIC PURPOSES | Final Rejection | UNIVERSITÉ DE MONTPELLIER |
| 18543604 | METHODS FOR INCREASING MENTAL WELL-BEING AND/OR HAPPINESS | Final Rejection | Fonterra Co-Operative Group Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy42.9% of resolved applications examined by Dennis Ignatius Armato Jr. were allowed (21 resolved cases), compared with 31.6% across Art Unit 1651 over the last five years.
This examiner's interview lift is +80.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Dennis Ignatius Armato Jr. took 1,250 days on average from filing to allowance.
Dennis Ignatius Armato Jr. examines applications in Art Unit 1651 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
